This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Fresenius Kabi Deutschland Gmbh. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovations of Eckart Grabenhorst
Introduction
Eckart Grabenhorst is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide conjugates. His work has implications for various medical applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Eckart Grabenhorst holds a patent for "Hasylated polypeptides." This invention relates to hydroxyalkylstarch (HAS)-polypeptide conjugates, which comprise one or more HAS molecules. Each HAS is conjugated to the polypeptide via a carbohydrate moiety or a thioether. The patent also details methods for the production of these conjugates. In a preferred embodiment, the polypeptide is erythropoietin (EPO), which is crucial for treating certain medical conditions.
Career Highlights
Grabenhorst is associated with Fresenius Kabi Deutschland GmbH, a company known for its focus on healthcare products. His role there has allowed him to further his research and development efforts in biotechnology. With a total of 1 patent, he has made a mark in his field, contributing to advancements that can improve patient care.
Collaborations
Throughout his career, Eckart Grabenhorst has collaborated with esteemed colleagues such as Harald Conradt and Manfred Nimtz. These partnerships have fostered an environment of innovation and have led to the successful development of new technologies in the biopharmaceutical sector.
Conclusion
Eckart Grabenhorst's work exemplifies the vital role of inventors in advancing medical science. His contributions, particularly in the area of polypeptide conjugates, highlight the importance of innovation in improving healthcare solutions.